title: Development and validation of a stability indicating UPLC method for determination of ticlopidine hydrochloride in its tablet formulation.
abstract: The objective of the current study was the development of a simple, precise and accurate isocratic reversed-phase stability indicating Ultra Performance Liquid Chromatography [UPLC] assay method and validated for determination of ticlopidine hydrochloride in solid pharmaceutical dosage forms. Isocratic separation was achieved on a Zorbax SB-C18 (50 mm × 4.6 mm, 1.8 μm) column using mobile phase of methanol-0.01 M ammonium acetate buffer, pH 5.0 (80:20, v/v) at a flow rate of 0.8 ml min(-1), the injection volume was 4.0 μl and the detection was carried out at 235 nm by using photo-diode array detector. The drug was subjected to oxidation, hydrolysis, photolysis and heat to apply stress condition. The method was validated for specificity, linearity, precision, accuracy, robustness and solution stability. The method was linear in the drug concentration range of 62.5-375 μg ml(-1) with a correlation coefficient of 0.9999. The precision (relative standard deviation - RSD) of six samples was 1.31% for repeatability and the intermediate precision [RSD] among six-sample preparation was 0.77%. The accuracy (recovery) was between 98.80% and 101.50%. Degradation products produced as a result of stress studies did not interfere with detection of ticlopidine hydrochloride and the assay can thus be considered stability indicating.
authors: Department of Chemistry, Saurashtra University, Rajkot 360 005, Gujarat, India.
authors: Vijay
authors: V
authors: Ram
authors: Govind
authors: G
authors: Kher
authors: Kapil
authors: K
authors: Dubal
authors: Bhavesh
authors: B
authors: Dodiya
authors: Hitendra
authors: H
authors: Joshi
keywords: Stability indicating assay; Tablet formulation; Ticlopidine hydrochloride; UPLC method
references: J Pharm Biomed Anal. 2002 Jun 15;28(6):1011-40
references: 12049968
references: J Pharm Biomed Anal. 2004 Nov 19;36(4):769-75
references: 15533669
references: J Chromatogr B Biomed Sci Appl. 1997 Jun 6;693(2):393-8
references: 9210444
references: Clin Cardiol. 2008 Mar;31(3 Suppl 1):I2-9
references: 18481818
references: J Mass Spectrom. 2004 Dec;39(12):1562-9
references: 15578632
references: Appl Spectrosc. 2008 Feb;62(2):251-7
references: 18284803
references: Drugs Today (Barc). 2008 May;44(5):331-52
references: 18548136
references: J Pharm Biomed Anal. 2001 Dec;26(5-6):891-7
references: 11600301
references: J Vasc Surg. 2008 Jul;48(1):144-9
references: 18482817
references: Drug Dev Ind Pharm. 2000 Apr;26(4):391-401
references: 10769780